novo nordisk lawsuit semaglutide Rybelsus - July 2026 Update Wegovy® Lawsuit | July 2026

What if semaglutide alone isn't enough for my menopausal weight gain

New Research: Muscle Loss and Metabolic Impact A July 2025 study presented at ENDO 2025 and covered by ScienceDaily found that women on GLP-1 drugs like Ozempic may lose up to 40% of their weight from muscle mass, not just fat

Patented Drug : Ozempics manufacturer holds the patent, meaning only they can produce and sell it under this brand name

The main risks are a temporary resurgence of GI side effects (nausea, constipation, diarrhea), temporary appetite suppression reduction during the low-dose titration phase, and a short-term weight loss pause as tirzepatide builds toward therapeutic levels

Effectiveness: Both Rybelsus and Ozempic are effective for blood sugar control in type 2 diabetes

Protecting yourself regardless of platform If you choose MEDVi or any compounded tirzepatide platform, take these steps to protect yourself against regulatory disruption: First, establish a relationship with a primary care provider or endocrinologist who can prescribe brand-name tirzepatide if needed